Literature DB >> 12167416

Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: a review and comparison of immunohistochemical markers.

Mark R Darling1, Johann W Schneider, Vincent M Phillips.   

Abstract

Polymorphous low-grade adenocarcinoma (PLGA) and adenoid cystic carcinoma (ACC) have several overlapping histological patterns, including cribriform, tubular and solid patterns. The overlapping clinicopathological features of PLGA and ACC may result in a diagnostic pitfall. ACC has a much worse prognosis than PLGA, making differentiation important for therapeutic and prognostic purposes. Histopathological features remain the most reliable criteria to distinguish between these two tumours. Although PLGA and ACC have many features in common, PLGA is uncommon in the major salivary glands. Histopathological distinction is therefore mainly a problem in tumours of minor salivary gland origin where small biopsies often contribute to diagnostic difficulties. This paper reviews studies which have utilised several immunohistochemical markers in attempts to distinguish between PLGA and ACC, and also studies which have focussed on the two tumours individually. The potential discriminating value of immunohistochemistry between cases of PLGA and ACC still remains controversial.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167416     DOI: 10.1016/s1368-8375(02)00003-9

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  27 in total

Review 1.  Challenges in Minor Salivary Gland Biopsies: A Practical Approach to Problematic Histologic Patterns.

Authors:  Lisa M Rooper
Journal:  Head Neck Pathol       Date:  2019-03-18

2.  Primary esophageal adenoid cystic carcinoma.

Authors:  Youn Ju Na; Ki-Nam Shim; Min-Jung Kang; Ji Min Jung; Chang Yun Ha; Hae Sun Jung; Su Jung Baik; Seong-Eun Kim; Sung-Ae Jung; Kwon Yoo; Il Hwan Moon; Min Sun Cho
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

3.  Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.

Authors:  Stephan Schwarz; Maximilian Müller; Tobias Ettl; Philipp Stockmann; Johannes Zenk; Abbas Agaimy
Journal:  Int J Clin Exp Pathol       Date:  2011-04-18

4.  Polymorphous low-grade adenocarcinoma of the epiglottis: A case report.

Authors:  Noppadol Larbcharoensub; Suda Sanpaphant; Patamintita Witoonpanich; Lojana Tuntiyatorn; Jumroon Tungkeeratichai; Wichit Cheewaruangroj
Journal:  Mol Clin Oncol       Date:  2016-02-16

5.  Malignant minor salivary gland tumors: a retrospective study of 27 cases.

Authors:  Astrid L D Kruse; Klaus W Grätz; Joachim A Obwegeser; Heinz-Theo Lübbers
Journal:  Oral Maxillofac Surg       Date:  2010-12

6.  Tracheal stenosis and adenocarcinoma in an olive baboon (Papio cynocephalus anubis).

Authors:  Kristina A Asselin; Jodi A Carlson Scholz; Caroline Zeiss
Journal:  Comp Med       Date:  2011-12       Impact factor: 0.982

7.  Misleading initial histological diagnosis of a polymorphous low-grade adenocarcinoma in situ ex pleomorphic adenoma-a case report.

Authors:  P W Kämmerer; A Kreft; T Toyoshima; B Al-Nawas; M O Klein
Journal:  Oral Maxillofac Surg       Date:  2009-06

8.  Polymorphous low grade adenocarcinoma has a consistent p63+/p40- immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma.

Authors:  Lisa Rooper; Rajni Sharma; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2014-06-27

9.  Differential expression of basement membrane type-IV collagen alpha1, alpha2, alpha5 and alpha6 chains among the histological subtypes of adenoid cystic carcinoma.

Authors:  Shuji Misumi; Ken-Ichi Iyama; Yumi Honda; Takao Kitano; Yoshikazu Sado; Yoshifumi Ninomiya; Masanori Shinohara
Journal:  Virchows Arch       Date:  2004-05-11       Impact factor: 4.064

Review 10.  [Differential diagnosis of basaloid salivary gland tumors].

Authors:  K T Jäkel; T Löning
Journal:  Pathologe       Date:  2004-02       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.